LIVE

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video

Trending Now

Transparency

Sarepta Shares Crash 25% After Third Patient Death Related Its Gene Therapy

Goldman, UBS Encouraged By Burberry's Turnaround Momentum After Earnings Print

Renter Nation Returns: Surge In Multi-Family Unit Starts & Permits Saves US Housing Market

Netflix Dips Despite Top- & Bottom-Line Beat, Higher Guidance

Citadel's Rubner Says Market Has "Higher, Then Lower Vibes"

Yield Curve Control? Why Not...

'DOGE' Effect Accelerates As 'Deep Tristate' Jobless Claims Hit 4 Year high

Trump: Sending Tariff Letters To More Than 150 Countries

Beige Book Spells Trouble For Powell: Mentions Of "Inflation" Tumble To 4 Year Low, As Growth Concerns Mount

Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval

Business June 07, 2021

This article is being updated.

Previous article: Consumer Credit Hits New Record Despite Unexpected Decline In Credit Card Usage Prev Next article: California And Nevada Are Now 100% In Drought Next

via CNBC June 7th 2021

MixedTimes.com
Business
Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval

© 2015-2025 MixedTimes All Rights Reserved.

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video